Search research articles
Contact Us
Filters
Showing results (1021-1030 of 1,074) with videos related to
Page
of 108
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 27, 2022
Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models
Kevin B Teuscher, Somenath Chowdhury, Kenneth M Meyers, et al.
Plos One
|
June 24, 2011
The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens
Oliver Liesenfeld, Iana Parvanova, Jens Zerrahn, et al.
British Journal of Haematology
|
April 3, 2015
A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study
Terzah M Horton, Richard A Drachtman, Lu Chen, et al.
Cancers
|
January 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry
Bertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
European Journal of Human Genetics : EJHG
|
October 13, 2018
Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics
Daniele Carrieri, Heidi C Howard, Caroline Benjamin, et al.
Cancers
|
March 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. <i>Cancers</i> 2026, <i>18</i>, 124
Bertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
Pediatric Blood & Cancer
|
March 21, 2014
Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA)
Naima A Al-Mulla, Prem Chandra, Mohammed Khattab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2014
Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia
Deepa Bhojwani, Noah D Sabin, Deqing Pei, et al.
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition
Gregory C Howard, Jing Wang, Kristie Lindsey Rose, et al.
Journal of Clinical and Translational Science
|
May 1, 2024
Strategies to promote language inclusion at 17 CTSA hubs
Linda Sprague Martinez, Cristina Araujo Brinkerhoff, Riana C Howard, et al.
Page
of 108
Search research articles
Search
Showing results (1021-1030 of 1,074) with videos related to
Sort By:
Page
of 108
Proceedings of the National Academy of Sciences of the United States of America
|
December 27, 2022
Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models
Kevin B Teuscher, Somenath Chowdhury, Kenneth M Meyers, et al.
Plos One
|
June 24, 2011
The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens
Oliver Liesenfeld, Iana Parvanova, Jens Zerrahn, et al.
British Journal of Haematology
|
April 3, 2015
A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study
Terzah M Horton, Richard A Drachtman, Lu Chen, et al.
Cancers
|
January 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry
Bertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
European Journal of Human Genetics : EJHG
|
October 13, 2018
Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics
Daniele Carrieri, Heidi C Howard, Caroline Benjamin, et al.
Cancers
|
March 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. <i>Cancers</i> 2026, <i>18</i>, 124
Bertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
Pediatric Blood & Cancer
|
March 21, 2014
Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA)
Naima A Al-Mulla, Prem Chandra, Mohammed Khattab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2014
Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia
Deepa Bhojwani, Noah D Sabin, Deqing Pei, et al.
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition
Gregory C Howard, Jing Wang, Kristie Lindsey Rose, et al.
Journal of Clinical and Translational Science
|
May 1, 2024
Strategies to promote language inclusion at 17 CTSA hubs
Linda Sprague Martinez, Cristina Araujo Brinkerhoff, Riana C Howard, et al.
Page
of 108